Human antibodies to pneumococcal surface protein A in health and disease

Pediatric Infectious Disease Journal

Volumn 19, Issue 2, 2000, Pages 134-138

  Virolainen, Anni ^a,c   Russell, William ^a   Crain, Marilyn J ^a   Rapola, Satu ^b   Käyhty, Helena ^b   Briles, David E ^a  

^a UNIVERSITY OF ALABAMA AT BIRMINGHAM   (United States)

^b NATIONAL PUBLIC HEALTH INSTITUTE   (Finland)

^c UNIVERSITY OF HELSINKI   (Finland)

Author keywords

Human antibodies; Pneumococcal surface protein A; Streptococcus pneumoniae

Indexed keywords

IMMUNOGLOBULIN G; PNEUMOCOCCUS VACCINE; POLYSACCHARIDE; PROTEIN A;

ADULT; ANTIBODY DETECTION; ANTIBODY RESPONSE; ANTIBODY TITER; ANTIGEN ANTIBODY COMPLEX; ARTICLE; CELL INVASION; CHILD; CONTROLLED STUDY; CROSS REACTION; ENZYME IMMUNOASSAY; FINLAND; GEOMETRY; HUMAN; IMMUNITY; IMMUNOBLOTTING; MAJOR CLINICAL STUDY; POLYACRYLAMIDE GEL ELECTROPHORESIS; PRIORITY JOURNAL; STREPTOCOCCUS INFECTION;

ADULT; ANTIBODIES, BACTERIAL; BACTERIAL PROTEINS; BLOTTING, WESTERN; CHILD, PRESCHOOL; CROSS REACTIONS; FINLAND; HUMANS; IMMUNOENZYME TECHNIQUES; INFANT; MIDDLE AGED; PNEUMOCOCCAL INFECTIONS; STREPTOCOCCUS PNEUMONIAE;

EID: 0033969480     PISSN: 08913668     EISSN: None     Source Type: Journal    
DOI: 10.1097/00006454-200002000-00011     Document Type: Article

References (15)

1. Johnston RB. Pathogenesis of pneumococcal pneumonia. Rev Infect Dis 1991;13(Suppl 6):S509-17.
2. Campbell GD, Silberman R. Drug resistant Streptococcus pneumoniae. Clin Infect Dis 1998;26:1188-95.
3. Gray BM. Pneumococcal infections in an era of multiple antibiotic resistance. Adv Pediatr Infect Dis 1995;11:55-100.
4. Eskola J, Käyhty H, Takala AK, et al. A randomized, prospective field trial of a conjugate vaccine in the protection of infants and young children against invasive Haemophilus influenzas type b disease. N Engl J Med 1990;323:1381-7.
5. Käyhty H, Ahman H, Rönnberg PR, Tillikainen R, Eskola J. Pneumococcal polysaccharide-meningococcal outer membrane protein complex conjugate vaccine is immunogenic in infants. J Infect Dis 1995;172:1273-8.
6. Black S, Shinefield H, Ray P, et al. Efficacy of heptavalent conjugate pneumococcal vaccine (Wyeth Lederle) in 37 000 infants and children: results of the northern California Kaiser Permanente efficacy trial [Abstract LB-9]. Presented at the 38th Interscience Conference on Antimicrobial Agents and Chemotherapy, San Diego, CA, September 24 to 27, 1998.
7. Rennels MB, Edwards KM, Keyserling HL, et al. Safety and immunogenicity of heptavalent pneumococcal vaccine conjugated to CRM197 in United States infants. Pediatrics 1998; 101:604-11.
8. Briles DE, Tart RC, Wu HY, Ralph BA, Russell MW, McDaniel LS. Systemic and mucosal protective immunity to pneumococcal surface protein A. Ann NY Acad Sci 1996;797: 118-26.
9. Crain MJ, Waltman WD, Turner JS, et al. Pneumococcal surface protein A (PspA) is serologically highly variable and is expressed by all clinically important capsular serotypes of Streptococcus pneumoniae. Infect Immun 1990;58:3293-9.
10. McDaniel LS, Yother J, Vijayakumar M, McGarry L, Guild WR, Briles DE. Use of insertional inactivation to facilitate studies of biological properties of pneumococcal surface protein A (PspA). J Exp Med 1987;165:381-94.
11. Yother J, Briles DE. Structural properties and evolutionary relationships of PspA, a surface protein of Streptococcus pneumoniae, as revealed by sequence analysis. J Bacteriol 1992;174:601-9.
12. Tart RC, McDaniel LS, Ralph BA, Briles DE. Truncated Streptococcus pneumoniae PspA molecules elicit cross-protective immunity against pneumococcal challenge in mice. J Infect Dis 1996;173:380-6.
13. Briles DE, King JD, Gray MA, McDaniel LS, Swiatlo E, Benton KA. PspA, a protection-eliciting pneumococcal protein: immunogenicity of isolated native PspA in mice. Vaccine 1996;14:858-67.
14. Virolainen A, Jero J, Kayhty H, Karma P, Eskola J, Leinonen M. Nasopharyngeal antibodies to pneumococcal pneumolysin in children with acute otitis media. Clin Diagn Lab Immunol. 1995;2:704-7.
15. Russell MW, Brown TA, Radl J, Haaijman JJ, Mestecky J. Assay of human IgA subclass antibodies in serum and secretions by means of monoclonal antibodies. J Immunol Methods 1986;87:87-93.